Home / AARTIPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AARTIPHARM.NS make money? Does AARTIPHARM.NS have pricing power? What's the Earnings Whisper? Will AARTIPHARM.NS profit more as the business scales? What is AARTIPHARM.NS's management track record? Is AARTIPHARM.NS's current price justified?

Aarti Pharmalabs Limited

₹873.65 +$129.45 (+17.39%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹863.8

Day Range

₹864.85₹890.65

Year Range

₹585₹1002.4

Market Cap

79.22B

AVG Volume

658.66K

Trailing/Forward PE

37.16/34.26

PEG ratio

0.86

Dividend Yield

0.40%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

AARTIPHARM.NS Revenue (INR) by year
Period	Revenue (INR)
2026	18.19B
2025	21.15B
2024	18.53B
2023	19.53B
2022	16.57B

Net Income (INR) · A

AARTIPHARM.NS Net Income (INR) by year
Period	Net Income (INR)
2026	1.87B
2025	2.72B
2024	2.17B
2023	1.93B
2022	1.22B

Operating Income (INR) · A

AARTIPHARM.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	2.98B
2025	3.77B
2024	3.13B
2023	2.8B
2022	1.65B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aarti Pharmalabs Limited

Video analysis: AARTIPHARM.NS

News: AARTIPHARM.NS

Similar companies